Chapter 10 : Neurovirological Aspects of HIV Infection in the HAART Era

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Neurovirological Aspects of HIV Infection in the HAART Era, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap10-1.gif /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap10-2.gif


The National Institute of Mental Health (NIMH) of the U.S. National Institutes of Health (NIH) organized a meeting to discuss clinical and basic research priorities on CNS-related comorbidities and complications in HIV-1-infected older populations. Of interest is a study in which it was demonstrated that HIV-1 RNA in cerebrospinal fl uid (CSF) is produced both from the peripheral blood and from the brain parenchyma in infected individuals. This study supports the notion that the remission of HAART-associated neurological disorders might be relevant to the decrease in peripheral viral load. The study involved comparison of viral and gene sequences from viral genomic DNA isolated either directly from tissues or coculturing methodology for retrieval of viral quasispecies. Other important findings of this study were that during antiretroviral therapy the virus present in the CSF declined rapidly, with an estimated half-life of 1 to 3 days. Viral genome dynamics also play an important role in immune evasion as well as emergence of drug-resistant quasispecies. Changes in the expression of various genes might provide an environment conducive to viral persistence in the brain. Technological strategies used in this study provide a paradigm to isolate HIV-1 from individual cell types and its characterization. Several studies in the past and long-term experience with HAART suggest that the HIV-1-associated severe neurological disorder, HIV-1-associated dementia (HAD), has been significantly reduced in countries where the health care infrastructure could afford this costly treatment.

Citation: Parveen Z, Acheampong E, Pomerantz R, Mukhtar M. 2009. Neurovirological Aspects of HIV Infection in the HAART Era, p 123-135. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch10

Key Concept Ranking

Mitogen-Activated Protein Kinase Pathway
Immune Systems
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Acheampong, E.,, Z. Parveen,, A. Mengistu,, N. Ngoubilly,, X. D. Cheng,, R. J. Pomerantz, and, M. Mukhtar. 2003. Statins control HIV-1 and ethanol-induced oxidative stress in human postmitotic neurons. Free Radic. Biol. Med. 35:499.
2. Acheampong, E. A.,, Z. Parveen,, L. W. Muthoga,, M. Kalayeh,, M. Mukhtar, and, R. J. Pomerantz. 2005. Human immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J. Virol. 79:42574269.
3. Adamson, D. C.,, T. M. Dawson,, M. C. Zink,, J. E. Clements, and, V. L. Dawson. 1996. Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol. Med. 2:417428.
4. Adle-Biassette, H.,, Y. Levy,, M. Colombel,, F. Poron,, S. Natchev,, C. Keohane, and, F. Gray. 1995. Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21:218227.
5. Alderson, M. R.,, T. W. Tough,, T. Davis-Smith,, S. Braddy,, B. Falk,, K. A. Schooley,, R. G. Goodwin,, C. A. Smith,, F. Ramsdell, and, D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:7177.
6. Alisky, J. M. 2007. The coming problem of HIV-associated Alzheimer’s disease. Med. Hypotheses 69:11401143.
7. Andreau, K.,, J. L. Perfettini,, M. Castedo,, D. Metivier,, V. Scott,, G. Pierron, and, G. Kroemer. 2004. Contagious apoptosis facilitated by the HIV-1 envelope: fusion-induced cell-to-cell transmission of a lethal signal. J. Cell Sci. 117:56435653.
8. Anthony, I. C.,, S. N. Ramage,, F. W. Carnie,, P. Simmonds, and, J. E. Bell. 2005. Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 64:529536.
9. Argyris, E. G.,, E. Acheampong,, G. Nunnari,, M. Mukhtar,, K. J. Williams, and, R. J. Pomerantz. 2003. Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. J. Virol. 77:1214012151.
10. Asahi, M.,, Z. Huang,, S. Thomas,, S. Yoshimura,, T. Sumii,, T. Mori,, J. Qiu,, S. Amin-Hanjani,, P. L. Huang,, J. K. Lia,, E. H. Lo, and, M. A. Moskowitz. 2005. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 25:722729.
11. Aweeka, F.,, A. Jayewardene,, S. Staprans,, S. E. Bellibas,, B. Kearney,, P. Lizak,, T. Novakovic-Agopian, and, R. W. Price. 1999. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20:3943.
12. Baeuerle, M.,, M. Schmitt-Haendle,, A. Taubald,, S. Mueller,, H. Walter,, C. Pfeiffer,, B. Manger, and, T. Harrer. 2005. Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART-case report and review of the literature. Eur. J. Med. Res. 10:309316.
13. Bagasra, O.,, E. Lavi,, L. Bobroski,, K. Khalili,, J. P. Pestaner, and, R. J. Pomerantz. 1996. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10:573585.
14. Bagetta, G.,, M. T. Corasaniti,, W. Malorni,, G. Rainaldi,, L. Berliocchi,, A. Finazzi-Agro, and, G. Nistico. 1996. The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. Neuroreport 7:17221724.
15. Baker, S. K.,, and M. A. Tarnopolsky. 2005. Statin-associated neuromyotoxicity. Drugs Today 41:267293.
16. Ball, J. K.,, E. C. Holmes,, H. Whitwell, and, U. Desselberger. 1994. Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy. J. Gen. Virol. 75(Pt. 4):6779.
17. Bandaru, V. V.,, J. C. McArthur,, N. Sacktor,, R. G. Cutler,, E. L. Knapp,, M. P. Mattson, and, N. J. Haughey. 2007. Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 68:14811487.
18. Barak, O.,, I. Goshen,, T. Ben-Hur,, J. Weidenfeld,, A. N. Taylor, and, R. Yirmiya. 2002. Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120. Brain Res. 933:98108.
19. Bautista, A. P. 2001. Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis. Free Radic. Biol. Med. 31:15271532.
20. Bell, J. E. 2004. An update on the neuropathology of HIV in the HAART era. Histopathology 45:549559.
21. Bell, J. E.,, A. Busuttil,, J. W. Ironside,, S. Rebus,, Y. K. Donaldson,, P. Simmonds, and, J. F. Peutherer. 1993. Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J. Infect. Dis. 168:818824.
22. Bijur, G. N.,, P. De Sarno, and, R. S. Jope. 2000. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J. Biol. Chem. 275:75837590.
23. Blanchard, P. 2004. Update on peripheral neuropathy in HIV-infection. HIV Treat. Bull. 5(3): http://www.i-base.info/pub/htb/v5/htb5-3/Update.html.
24. Bosel, J.,, F. Gandor,, C. Harms,, M. Synowitz,, U. Harms,, P. C. Djoufack,, D. Megow,, U. Dirnagl,, H. Hortnagl,, K. B. Fink, and, M. Endres. 2005. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J. Neurochem. 92:13861398.
25. Bratanich, A. C.,, C. Liu,, J. C. McArthur,, T. Fudyk,, J. D. Glass,, S. Mittoo,, G. A. Klassen, and, C. Power. 1998. Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity. J. Neurovirol. 4:387393.
26. Brew, B. J.,, L. Pemberton,, P. Cunningham, and, M. G. Law. 1997. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J. Infect. Dis. 175:963966.
27. Brinley, F. J.,, Jr., C. A. Pardo, and, A. Verma. 2001. Human immunodeficiency virus and the peripheral nervous system workshop. Arch. Neurol. 58:15611566.
28. Burkala, E. J.,, J. He,, J. T. West,, C. Wood, and, C. K. Petito. 2005. Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. AIDS 19:675684.
29. Calabro, P.,, and E. T. Yeh. 2005. The pleiotropic effects of statins. Curr. Opin. Cardiol. 20:541546.
30. Canto-Nogues, C.,, S. Sanchez-Ramon,, S. Alvarez,, C. Lacruz, and, M. A. Munoz-Fernandez. 2005. HIV-1 infection of neurons might account for progressive HIV-1-associated encephalopathy in children. J. Mol. Neurosci. 27:7989.
31. Casanova-Sotolongo, P.,, P. Casanova-Carrillo, and, C. Casanova-Carrillo. 2003. Diseases of the peripheral and visual nervous system during infection with human immunodeficiency virus. Rev. Neurol. 37:481485. (In French.)
32. Cavert, W.,, D. W. Notermans,, K. Staskus,, S. W. Wietgrefe,, M. Zupancic,, K. Gebhard,, K. Henry,, Z. Q. Zhang,, R. Mills,, H. McDade,, C. M. Schuwirth,, J. Goudsmit,, S. A. Danner, and, A. T. Haase. 1997. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960964.
33. Childs, E. A.,, R. H. Lyles,, O. A. Selnes,, B. Chen,, E. N. Miller,, B. A. Cohen,, J. T. Becker,, J. Mellors, and, J. C. McArthur. 1999. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52:607613.
34. Chun, T. W.,, L. Carruth,, D. Finzi,, X. Shen,, J. A. DiGiuseppe,, H. Taylor,, M. Hermankova,, K. Chadwick,, J. Margolick,, T. C. Quinn,, Y. H. Kuo,, R. Brookmeyer,, M. A. Zeiger,, P. Barditch-Crovo, and, R. F. Siliciano. 1997a. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183188.
35. Chun, T. W.,, L. Stuyver,, S. B. Mizell,, L. A. Ehler,, J. A. Mican,, M. Baseler,, A. L. Lloyd,, M. A. Nowak, and, A. S. Fauci. 1997b. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:1319313197.
36. Clayton, A.,, and T. Mughal. 2004. The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era? Hematol. Oncol. 22:111120.
37. Corasaniti, M. T.,, C. Bellizzi,, R. Russo,, C. Colica,, D. Amantea, and, G. Di Renzo. 2003. Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells. Toxicol. Lett. 139:213219.
38. Corasaniti, M. T.,, D. Amante,, R. Russo,, S. Piccirilli,, A. Leta,, M. Corazzari,, G. Nappi, and, G. Bagetta. 2005. 17beta-Estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurotoxicology 26:893903.
39. Corboy, J. R.,, J. M. Buzy,, M. C. Zink, and, J. E. Clements. 1992. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258:18041808.
40. Coyle, J. T.,, and P. Puttfarcken. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689695.
41. Daniel, V.,, C. Susal,, A. Melk,, R. Weimer,, M. Kropelin,, R. Zimmermann,, A. Huth-Kuhne,, C. Uhle, and, G. Opelz. 1999. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients. Immunol. Lett. 69:283289.
42. Davies, J.,, I. P. Everall,, S. Weich,, J. McLaughlin,, F. Scaravilli, and, P. L. Lantos. 1997. HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS 11:11451150.
43. Delanty, N.,, C. J. Vaughan, and, N. Sheehy. 2001. Statins and neuroprotection. Expert Opin. Investig. Drugs 10:18471853.
44. del Real, G.,, S. Jimenez-Baranda,, E. Mira,, R. A. Lacalle,, P. Lucas,, C. Gomez-Mouton,, M. Alegret,, J. M. Pena,, M. Rodriguez-Zapata,, M. Alvarez-Mon,, A. C. Martinez, and, S. Manes. 2004. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200:541547.
45. Del Valle, L.,, and S. Pina-Oviedo. 2006. HIV disorders of the brain; pathology and pathogenesis. Front. Biosci. 11:718732.
46. Deshpande, M.,, J. Zheng,, K. Borgmann,, R. Persidsky,, L. Wu,, C. Schellpeper, and, A. Ghorpade. 2005. Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotox. Res. 7:183192.
47. Diesing, T. S.,, S. Swindells,, H. Gelbard, and, H. E. Gendelman. 2002. HIV-1-associated dementia: a basic science and clinical perspective. AIDS Read. 12:358368.
48. Dou, H.,, K. Birusingh,, J. Faraci,, S. Gorantla,, L. Y. Poluektova,, S. B. Maggirwar,, S. Dewhurst,, H. A. Gelbard, and, H. E. Gendelman. 2003. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J. Neurosci. 23:91629170.
49. Dougherty, R. H.,, and J. McArthur. 2002. Progression of HIV-associated dementia treated with highly active antiretroviral therapy, abstr. P06.035. Neurology 58:A441.
50. Edinger, A. L.,, J. L. Mankowski,, B. J. Doranz,, B. J. Margulies,, B. Lee,, J. Rucker,, M. Sharron,, T. L. Hoffman,, J. F. Berson,, M. C. Zink,, V. M. Hirsch,, J. E. Clements, and, R. W. Doms. 1997. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc. Natl. Acad. Sci. USA 94:1474214747.
51. Eggers, C.,, K. Hertogs,, H. J. Sturenburg,, J. van Lunzen, and, H. J. Stellbrink. 2003. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration. AIDS 17:18971906.
52. Ellis, R.,, K. Robertson,, L. Moo,, D. Clifford,, Y. Yang,, C. Yiannoutsos, and, S. Evans. 2004. NARC007: clinical validation of the ACTG NeuroScreen, abstr. no. 493. 11th Conf. Retrovir. Opportun. Infect.
53. Ellis, R. J.,, A. C. Gamst,, E. Capparelli,, S. A. Spector,, K. Hsia,, T. Wolfson,, I. Abramson,, I. Grant, and, J. A. McCutchan. 2000. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54:927936.
54. Ellis, R. J.,, K. Hsia,, S. A. Spector,, J. A. Nelson,, R. K. Heaton,, M. R. Wallace,, I. Abramson,, J. H. Atkinson,, I. Grant,, J. A. McCutchan, et al. 1997. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann. Neurol. 42:679688.
55. Evers, S.,, A. Rahmann,, S. Schwaag,, A. Frese,, D. Reichelt, and, I. W. Husstedt. 2004. Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance. AIDS Res. Hum. Retrovir. 20:483491.
56. Fang, J.,, E. Acheampong,, R. Dave,, F. Wang,, M. Mukhtar, and, R. J. Pomerantz. 2005. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes. Virology 336:299307.
57. Finzi, D.,, M. Hermankova,, T. Pierson,, L. M. Carruth,, C. Buck,, R. E. Chaisson,, T. C. Quinn,, K. Chadwick,, J. Margolick,, R. Brookmeyer,, J. Gallant,, M. Markowitz,, D. Ho,, D. D. Richman, and, R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:12951300.
58. Fischer-Smith, T.,, S. Croul,, A. E. Sverstiuk,, C. Capini,, D. L’Heureux,, E. G. Regulier,, M. W. Richardson,, S. Amini,, S. Morgello,, K. Khalili, and, J. Rappaport. 2001. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 7:528541.
59. Freed, E. O. 2004. HIV-1 and the host cell: an intimate association. Trends Microbiol. 12:170177.
60. Garden, G. A. 2002. Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40:240251.
61. Gazarin, S.,, H. Abd-El-Hady,, O. Gheith,, M. Rasem,, M. Saad,, K. El-Sayed,, M. Sobh, and, G. Amer. 2002. Neuromuscular toxicity in nephrotic patients treated with fluvastatin. J. Nephrol. 15:690695.
62. Giguere, J. F.,, and M. J. Tremblay. 2004. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J. Virol. 78:1206212065.
63. Gilbert, C.,, M. Bergeron,, S. Methot,, J. F. Giguere, and, M. J. Tremblay. 2005. Statins could be used to control replication of some viruses, including HIV-1. Viral Immunol. 18:474489.
64. Glass, J. D.,, H. Fedor,, S. L. Wesselingh, and, J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:755762.
65. Gonzalez-Scarano, F.,, and J. Martin-Garcia. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5:6981.
66. Gorry, P. R.,, G. Bristol,, J. A. Zack,, K. Ritola,, R. Swanstrom,, C. J. Birch,, J. E. Bell,, N. Bannert,, K. Crawford,, H. Wang,, D. Schols,, E. De Clercq,, K. Kunstman,, S. M. Wolinsky, and, D. Gabuzda. 2001. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J. Virol. 75:1007310089.
67. Gosztonyi, G.,, J. Artigas,, L. Lamperth, and, H. D. Webster. 1994. Human immunodeficiency virus (HIV) distribution in HIV encephalitis: study of 19 cases with combined use of in situ hybridization and immunocytochemistry. J. Neuropathol. Exp. Neurol. 53:521534.
68. Gray, F.,, H. Adle-Biassette,, F. Chretien,, G. Lorin de la Grandmaison,, G. Force, and, C. Keohane. 2001. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin. Neuropathol. 20:146155.
69. Gray, F.,, F. Chretien,, A. V. Vallat-Decouvelaere, and, F. Scaravilli. 2003. The changing pattern of HIV neuropathology in the HAART era. J. Neuropathol. Exp. Neurol. 62:429440.
70. Green, D. A.,, E. Masliah,, H. V. Vinters,, P. Beizai,, D. J. Moore, and, C. L. Achim. 2005. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407411.
71. Grinspoon, S. K. 2005. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am. J. Med. 118(Suppl. 2):S23S28.
72. Grover, S. A.,, L. Coupal,, N. Gilmore, and, J. Mukherjee. 2005. Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy. Am. J. Cardiol. 95:586591.
73. Harouse, J. M.,, C. Kunsch,, H. T. Hartle,, M. A. Laughlin,, J. A. Hoxie,, B. Wigdahl, and, F. Gonzalez-Scarano. 1989. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63:25272533.
74. Harrington, P. R,, D. W. Haas,, K. Ritola, and, R. Swanstrom. 2005. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J. Virol. 79:79597966.
75. He, J.,, Y. Chen,, M. Farzan,, H. Choe,, A. Ohagen,, S. Gartner,, J. Busciglio,, X. Yang,, W. Hofmann,, W. Newman,, C. R. Mackay,, J. Sodroski, and, D. Gabuzda. 1997a. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645649.
76. He, J.,, C. M. deCastro,, G. R. Vandenbark,, J. Busciglio, and, D. Gabuzda. 1997b. Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene. Proc. Natl. Acad. Sci. USA 94:39543959.
77. Herbeuval, J. P.,, J. C. Grivel,, A. Boasso,, A. W. Hardy,, C. Chougnet,, M. J. Dolan,, H. Yagita,, J. D. Lifson, and, G. M. Shearer. 2005. CD4+ T cell death induced by infectious and noninfectious HIV-1: role of type I interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 106:35243531.
78. Hesselgesser, J.,, and R. Horuk. 1999. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:1326.
79. Hetman, M.,, S. L. Hsuan,, A. Habas,, M. J. Higgins, and, Z. Xia. 2002. ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons. J. Biol. Chem. 277:4957749584.
80. Hoeflich, K. P.,, J. Luo,, E. A. Rubie,, M. S. Tsao,, O. Jin, and, J. R. Woodgett. 2000. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406:8690.
81. Hulgan, T.,, D. W. Haas,, J. L. Haines,, M. D. Ritchie,, G. K. Robbins,, R. W. Shafer,, D. B. Clifford,, A. R. Kallianpur,, M. Summar, and, J. A. Canter. 2005. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19:13411349.
82. Jana, A.,, and K. Pahan. 2004. Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J. Neurosci. 24:95319540.
83. Kaul, M.,, G. A. Garden, and, S. A. Lipton. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988994.
84. Kaul, M.,, and S. A. Lipton. 2006. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4:307318.
85. Kaul, M.,, J. Zheng,, S. Okamoto,, H. E. Gendelman, and, S. A. Lipton. 2005. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12(Suppl.1):878892.
86. Kiessling, A. A.,, S. J. Eyre, and, B. D. Desmarais. 2005. Detection of drug-resistant HIV-1 strains. Methods Mol. Biol. 304:287313.
87. Koedel, U.,, B. Kohleisen,, B. Sporer,, F. Lahrtz,, V. Ovod,, A. Fontana,, V. Erfle, and, H. W. Pfister. 1999. HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J. Immunol. 163:12371245.
88. Kolson, D. L. 2002. Neuropathogenesis of central nervous system HIV-1 infection. Clin. Lab. Med. 22:703717.
89. Kramer-Hammerle, S.,, I. Rothenaigner,, H. Wolff,, J. E. Bell, and, R. Brack-Werner. 2005. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111:194213.
90. Kretz, A.,, C. Schmeer,, S. Tausch, and, S. Isenmann. 2005. Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo. Neurobiol. Dis. 21:421430.
91. Kruman, I. I.,, A. Nath, and, M. P. Mattson. 1998. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 154:276288.
92. Lane, J. H.,, A. F. Tarantal,, D. Pauley,, M. Marthas,, C. J. Miller, and, A. A. Lackner. 1996. Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero. Am. J. Pathol. 149:10971104.
93. Langford, T. D.,, S. L. Letendre,, G. J. Larrea, and, E. Masliah. 2003. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 13:195210.
94. Lawrence, D. M.,, and E. O. Major. 2002. HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect. 4:301308.
95. Lehrman, G.,, I. B. Hogue,, S. Palmer,, C. Jennings,, C. A. Spina,, A. Wiegand,, A. L. Landay,, R. W. Coombs,, D. D. Richman,, J. W. Mellors,, J. M. Coffin,, R. J. Bosch, and, D. M. Margolis. 2005. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366:549555.
96. Li, X. L.,, T. Moudgil,, H. V. Vinters, and, D. D. Ho. 1990. CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J. Virol. 64:13831387.
97. Liao, Z.,, D. R. Graham, and, J. E. Hildreth. 2003. Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res. Hum. Retrovir. 19:675687.
98. Lipton, S. A. 1992. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42:14031405.
99. Liu, N. Q.,, A. S. Lossinsky,, W. Popik,, X. Li,, C. Gujuluva,, B. Kriederman,, J. Roberts,, T. Pushkarsky,, M. Bukrinsky,, M. Witte,, M. Weinand, and, M. Fiala. 2002. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J. Virol. 76:66896700.
100. Maggirwar, S. B.,, N. Tong,, S. Ramirez,, H. A. Gelbard, and, S. Dewhurst. 1999. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J. Neurochem. 73:578586.
101. Marechal, V.,, M. C. Prevost,, C. Petit,, E. Perret,, J. M. Heard, and, O. Schwartz. 2001. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 75:1116611177.
102. McArthur, J. C.,, N. Haughey,, S. Gartner,, K. Conant,, C. Pardo,, A. Nath, and, N. Sacktor. 2003. Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirol. 9:205221.
103. Moncunill, G.,, E. Negredo,, L. Bosh,, J. Vilarrasa,, M. Witvrouw,, A. Llano,, B. Clotet, and, J. A. Este. 2005. Evaluation of the anti-HIV activity of statins. AIDS 19:16971700.
104. Moses, A. V.,, and J. A. Nelson. 1994. HIV infection of human brain capillary endothelial cells-implications for AIDS dementia. Adv. Neuroimmunol. 4:239247.
105. Mukhtar, M. 2005. Evolution of biomarkers: drug discovery to personalized medicine. Drug Discov. Today 10:121128.
106. Mukhtar, M.,, E. Acheampong,, Z. Parveen, and, R. J. Pomerantz. 2005. T-cells and excitotoxicity—HIV-1 and other neurodegenerative disorders. Neuromol. Med. 7:265273.
107. Mukhtar, M.,, H. Duke,, M. BouHamdan, and, R. J. Pomerantz. 2000. Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir. Hum. Gene Ther. 11:347359.
108. Mukhtar, M.,, S. Harley,, P. Chen,, M. BouHamdan,, C. Patel,, E. Acheampong,, R. J. Pomerantz. 2002. Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN. Virology 297:7888.
109. Mukhtar, M.,, A. Mengistu,, E. Acheampong,, J. Sullivan,, G. Nunnari,, E. G. Argyris,, M. Kalayeh,, R. J. Pomerantz, and, K. J. Williams. 2003. Statins block enhanced expression of matrix metalloproteinases (MMPs) by virally infected monocytes and T-cells and thereby normalize their transvascular transmigration. A novel therapeutic approach to HIV-1 neuroinvasion. Circulation 108:487.
110. Nath, A.,, and N. Sacktor. 2006. Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system. Curr. Opin. Neurol. 19:358361.
111. Nguyen, D. H.,, and D. D. Taub. 2004. Targeting lipids to prevent HIV infection. Mol. Interv. 4:318320.
112. Nosheny, R. L.,, A. Bachis,, E. Acquas, and, I. Mocchetti. 2004. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur. J. Neurosci. 20:28572864.
113. Nunn, M. F. 2006. NeuroAIDS: a neuroscience problem with global impact. Curr. HIV Res. 4:245247.
114. Nuovo, G. J.,, F. Gallery,, P. MacConnell, and, A. Braun. 1994. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144:659666.
115. Ozdener, H. 2005. Molecular mechanisms of HIV-1 associated neurodegeneration. J. Biosci. 30:391405.
116. Patel, A. K.,, K. K. Patel,, S. D. Shah, and, J. Desai. 2006. Immune reconstitution syndrome presenting with cerebral varicella zoster vasculitis in HIV-1-infected patient: a case report. J. Int. Assoc. Physicians AIDS Care (Chicago) 5:157160.
117. Patel, C. A.,, M. Mukhtar, and, R. J. Pomerantz. 2000. Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J. Virol. 74:97179726.
118. Patel, C. A.,, M. Mukhtar,, S. Harley,, J. Kulkosky, and, R. J. Pomerantz. 2002. Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons. J. Neurovirol. 8:8699.
119. Perelson, A. S.,, P. Essunger,, Y. Cao,, M. Vesanen,, A. Hurley,, K. Saksela,, M. Markowitz, and, D. D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188191.
120. Perelson, A. S.,, A. U. Neumann,, M. Markowitz,, J. M. Leonard, and, D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:15821586.
121. Persidsky, Y.,, J. Limoges,, R. McComb,, P. Bock,, T. Baldwin,, W. Tyor,, A. Patil,, H. S. Nottet,, L. Epstein,, H. Gelbard,, E. Flanagan,, J. Reinhard,, S. J. Pirruccello, and, H. E. Gendelman. 1996. Human immunodeficiency virus encephalitis in SCID mice. Am. J. Pathol. 149:10271053.
122. Pialoux, G.,, S. Fournier,, A. Moulignier,, J. D. Poveda,, F. Clavel, and, B. Dupont. 1997. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS 11:13021303.
123. Pomerantz, R. J. 1999. Residual HIV-1 disease in the era of highly active antiretroviral therapy. N. Engl. J. Med. 340:16721674.
124. Pomerantz, R. J. 2001. Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence. AIDS 15:12011211.
125. Pomerantz, R. J. 2002. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication. Clin. Infect. Dis. 34:9197.
126. Pomerantz, R. J. 2004. Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis. DNA Cell Biol. 23:227238.
127. Pomerantz, R. J.,, and D. L. Horn. 2003. Twenty years of therapy for HIV-1 infection. Nat. Med. 9:867873.
128. Pozio, E. 2004. Highly Active AntiRetroviral Therapy and opportunistic protozoan infections. Parassitologia 46:8993. (In Italian.)
129. Rafalowska, J. 1998. HIV-1-infection in the CNS. A pathogenesis of some neurological syndromes in the light of recent investigations. Folia Neuropathol. 36:211216.
130. Ranki, A.,, M. Nyberg,, V. Ovod,, M. Haltia,, I. Elovaara,, R. Raininko,, H. Haapasalo, and, K. Krohn. 1995. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9:10011008.
131. Rappaport, J.,, J. Joseph,, S. Croul,, G. Alexander,, L. Del Valle,, S. Amini, and, K. Khalili. 1999. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J. Leukoc. Biol. 65:458465.
132. Resnick, L.,, J. R. Berger,, P. Shapshak, and, W. W. Tourtellotte. 1988. Early penetration of the blood-brain-barrier by HIV. Neurology 38:914.
133. Riedel, D. J.,, C. A. Pardo,, J. McArthur, and, A. Nath. 2006. Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat. Clin. Pract. Neurol. 2:557565.
134. Ritola, K.,, K. Robertson,, S. A. Fiscus,, C. Hall, and, R. Swanstrom. 2005. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J. Virol. 79:1083010834.
135. Roger, P. M.,, J. P. Breittmayer,, C. Arlotto,, P. Pugliese,, C. Pradier,, G. Bernard-Pomier,, P. Dellamonica, and, A. Bernard. 1999. Highly active antiretroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin. Exp. Immunol. 118:412416.
136. Ryzhova, E. V.,, P. Crino,, L. Shawver,, S. V. Westmoreland,, A. A. Lackner, and, F. Gonzalez-Scarano. 2002. Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples. Virology 297:5767.
137. Sacktor, N. C.,, R. L. Skolasky,, R. H. Lyles,, D. Esposito,, O. A. Selnes, and, J. C. McArthur. 2000. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J. Neurovirol. 6:8488.
138. Saito, Y.,, L. R. Sharer,, L. G. Epstein,, J. Michaels,, M. Mintz,, M. Louder,, K. Golding,, T. A. Cvetkovich, and, B. M. Blumberg. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44:474481.
139. Salemi, M.,, S. L. Lamers,, S. Yu,, T. de Oliveira,, W. M. Fitch, and, M. S. McGrath. 2005. Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J. Virol. 79:1134311352.
140. Shapshak, P.,, D. M. Segal,, K. A. Crandall,, R. K. Fujimura,, B. T. Zhang,, K. Q. Xin,, K. Okuda,, C. K. Petito,, C. Eisdorfer, and, K. Goodkin. 1999. Independent evolution of HIV type 1 in different brain regions. AIDS Res. Hum. Retrovir. 15:811820.
141. Shi, B.,, U. De Girolami,, J. He,, S. Wang,, A. Lorenzo,, J. Busciglio, and, D. Gabuzda. 1996. Apoptosis induced by HIV-1 infection of the central nervous system. J. Clin. Investig. 98:19791990.
142. Shi, B.,, J. Raina,, A. Lorenzo,, J. Busciglio, and, D. Gabuzda. 1998. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4:281290.
143. Siliciano, R. F. 2005. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution. Top. HIV Med. 13:96100.
144. Singh, I. N.,, R. J. Goody,, C. Dean,, N. M. Ahmad,, S. E. Lutz,, P. E. Knapp,, A. Nath, and, K. F. Hauser. 2004. Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. J. Neurovirol. 10:141151.
145. Smit, T. K.,, B. J. Brew,, W. Tourtellotte,, S. Morgello,, B. B. Gelman, and, N. K. Saksena. 2004. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J. Virol. 78:1013310148.
146. Solas, C.,, A. Lafeuillade,, P. Halfon,, S. Chadapaud,, G. Hittinger, and, B. Lacarelle. 2003. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 47:238243.
147. Spector, S. A.,, K. Hsia,, D. Pratt,, J. Lathey,, J. A. McCutchan,, J. E. Alcaraz,, J. H. Atkinson,, S. Gulevich,, M. Wallace,, I. Grant, et al. 1993. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J. Infect. Dis. 168:6874.
148. Sperber, K.,, and L. Shao. 2003. Neurologic consequences of HIV infection in the era of HAART. AIDS Patient Care STDs 17:509518.
149. Sporer, B.,, U. Koedel,, R. Paul,, B. Kohleisen,, V. Erfle,, A. Fontana, and, H. W. Pfister. 2000. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J. Neuroimmunol. 102:1230.
150. Tashima, K. T.,, A. M. Caliendo,, M. Ahmad,, J. M. Gormley,, W. D. Fiske,, J. M. Brennan, and, T. P. Flanigan. 1999. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy. J. Infect. Dis. 180:862864.
151. Thomas, S. A. 2004. Anti-HIV drug distribution to the central nervous system. Curr. Pharm. Des. 10:13131324.
152. Toborek, M.,, Y. W. Lee,, G. Flora,, H. Pu,, I. E. Andras,, E. Wylegala,, B. Hennig, and, A. Nath. 2005. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell. Mol. Neurobiol. 25:181199.
153. Tornatore, C.,, R. Chandra,, J. R. Berger, Jr., and, E. O. Major. 1994. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481487.
154. Tozzi, V.,, P. Balestra,, S. Galgani,, P. Narciso,, F. Ferri,, G. Sebastiani,, C. D’Amato,, C. Affricano,, F. Pigorini,, F. M. Pau,, A. De Felici, and, A. Benedetto. 1999. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 13:18891897.
155. Tozzi, V.,, P. Balestra,, R. Bellagamba,, A. Corpolongo,, M. F. Salvatori,, U. Visco-Comandini,, C. Vlassi,, M. Giulianelli,, S. Galgani,, A. Antinori, and, P. Narciso. 2007. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J. Acquir. Immune Defic. Syndr. 45:174182.
156. van der Sandt, I. C.,, C. M. Vos,, L. Nabulsi,, M. C. Blom-Roosemalen,, H. H. Voorwinden,, A. G. de Boer, and, D. D. Breimer. 2001. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier. AIDS 15:483491.
157. Vaughan, C. J.,, and N. Delanty. 1999. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30:19691973.
158. von Giesen, H. J.,, H. Koller,, A. Theisen, and, G. Arendt. 2002. Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 29:363367.
159. Wang, Z.,, G. Trillo-Pazos,, S. Y. Kim,, M. Canki,, S. Morgello,, L. R. Sharer,, H. A. Gelbard,, Z. Z. Su,, D. C. Kang,, A. I. Brooks,, P. B. Fisher, and, D. J. Volsky. 2004. Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J. Neurovirol. 10(Suppl. 1):S25S32.
160. Waters, L.,, J. Stebbing,, R. Jones,, S. Mandalia,, M. Bower,, M. Stefanovic,, M. Nelson, and, B. Gazzard. 2005. The effect of statins on HIV rebound and blips. J. Acquir. Immune Defic. Syndr. 39:637638.
161. Weissman, D.,, R. L. Rabin,, J. Arthos,, A. Rubbert,, M. Dybul,, R. Swofford,, S. Venkatesan,, J. M. Farber, and, A. S. Fauci. 1997. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389:981985.
162. Wood, N.,, L. Tyfield, and, J. Bidwell. 1993. Rapid classification of phenylketonuria genotypes by analysis of heteroduplexes generated by PCR-amplifiable synthetic DNA. Hum. Mutat. 2:131137.
163. Yrjanheikki, J.,, J. Koistinaho,, M. Kettunen,, R. A. Kauppinen,, K. Appel,, M. Hull, and, B. L. Fiebich. 2005. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res. 1052:174179.
164. Yue, F. Y.,, C. M. Kovacs,, R. C. Dimayuga,, X. X. Gu,, P. Parks,, R. Kaul, and, M. A. Ostrowski. 2005. Preferential apoptosis of HIV-1-specific CD4+ T cells. J. Immunol. 174:21962204.
165. Zhang, K.,, F. Rana,, C. Silva,, J. Ethier,, K. Wehrly,, B. Chesebro, and, C. Power. 2003. Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J. Virol. 77:68996912.
166. Zheng, J.,, M. R. Thylin,, A. Ghorpade,, H. Xiong,, Y. Persidsky,, R. Cotter,, D. Niemann,, M. Che,, Y. C. Zeng,, H. A. Gelbard,, R. B. Shepard,, J. M. Swartz, and, H. E. Gendelman. 1999. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98:185200.
167. Zink, M. C.,, J. Uhrlaub,, J. DeWitt,, T. Voelker,, B. Bullock,, J. Mankowski,, P. Tarwater,, J. Clements, and, S. Barber. 2005. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293:20032011.


Generic image for table

Effects of HAART on HAD and associated neurological disorders

Citation: Parveen Z, Acheampong E, Pomerantz R, Mukhtar M. 2009. Neurovirological Aspects of HIV Infection in the HAART Era, p 123-135. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch10

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error